CHICAGO — Cangrelor infusion in adults with CAD pretreated with ticagrelor was associated with enhanced platelet inhibition compared with placebo, with no observed drug-drug interactions in the cangrelor group, researchers reported.“We know the current label for the use of cangrelor is for patients who have not been pretreated with an oral P2Y12 inhibitor,” Dominick J.
Florida International University
Search
Scott R. MacKenzie Foundation awards $350,000 in support of two-year clinical trial
March 3, 2021 at 12:00am
Diana Azzam, a researcher in the Robert Stempel College of Public Health & Social Work, will collaborate with Cleveland Clinic Florida on a study to find new treatment options for cancer patients.
The research, funded by a $350,000 grant from the Scott R. MacKenzie Foundation, focuses on the clinical utility of drug sensitivity testing and genomic profiling to treat sarcomas, one of the most common types of aggressive, malignant tumors.
Azzam, assistant professor in the Department of Environmental Health Sciences, will test the efficacy of a series of clinically approved compounds on tumor tissue samples. The drugs she determines to be most effective on the patient’s tumor cells will be used to guide treatments in the clinic.